• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Novo Boosts Wegovy Pill Case Before FDA Decision

    FIERCE PHARMA

    Novo, BMS Layoffs Leave Over 500 Jobless in New Jersey

    BIOSPACE

    6 Pharma Layoffs Could Eliminate Over 39,000 Jobs

    BIOSPACE

    NJ layoffs: Novo Nordisk dismisses 263, BMS cuts 282 workers

    FIERCE PHARMA

    Indian Pharma Giants Dr Reddy`s and Macleods Gear Up for Ozempic

    ECONOMICTIMES

    Novo Says Wegovy Pill Shows Comparable Weight-Loss to Injectable

    REUTERS

    Novo Pushes Ahead with Amylin After Seeing Ph. 3 Tolerability

    FIERCE BIOTECH

    Novo Holdings in talks to buy into Surya Hospitals

    ECONOMICTIMES

    EU Approves Novo`s Oral Semaglutide, Reduce Cardiovascular Death

    GLOBENEWSWIRE

    Novo’s Wegovy Cuts Food Noise, Lifts Mental Well-Being

    GLOBENEWSWIRE

    Novo Nordisk Mandates Employee Office Return by Jan. 1

    FIERCE PHARMA

    Novo Nordisk Streamlines Operations for Growth Reinvestment

    GLOBENEWSWIRE

    Wegovy-Maker Novo to Slash 9,000 Jobs as Competition Heats Up

    REUTERS

    Novo, Lilly Obesity Drugs Deemed `Highly Cost-Effective` by ICER

    FIERCE PHARMA

    Novonesis, Novo Nordisk to Enhance Metabolic Health Solutions

    GLOBENEWSWIRE

    WHO Includes GLP-1s in Essential Medicines List

    BIOSPACE

    Europe Warns of Surge in Illegal Obesity Drugs

    FIERCE PHARMA

    Novo Nordisk to Unveil Semaglutide Data on `Food Noise`

    GLOBENEWSWIRE

    Novo Nordisk Partners with Apollo Clinics for Obesity Management

    ECONOMICTIMES

    Novo’s Wegovy Cuts Risk of Heart Attack or Death by 57%

    GLOBENEWSWIRE

    Novo`s Wegovy Cuts Heart Risk by 57% versus Rival Lilly Drug

    REUTERS

    Novo Seeks Obesity Refresh with $550 M Replicate Deal

    FIERCE BIOTECH

    Catalent`s Newly Acquired Novo Plant Under FDA Scrutiny

    FIERCE PHARMA

    CDSCO issues Alert on Novo Drugs After Reported Theft

    ECONOMICTIMES

    Natco Pharma Sues Novo Nordisk Over Generic Drug Push

    ECONOMICTIMES

    Drugmaker Novo Nordisk Freezes Hiring for Non-Critical Jobs

    REUTERS

    Parker Waichman Files Suit for Ozempic-Linked NAION Vision Loss

    PR NEWSWIRE

    Novo to Showcase Wegovy & Ozempic Benefits at ESC Congress 2025

    GLOBENEWSWIRE

    Canada Approves Ozempic to Cut Risk of Kidney Failure

    REUTERS

    Wegovy`s Approval Highlights Viability of High-Dose Peptides

    BIOSPACE

    Novo Nordisk A/S: Board Members and Executives Trade Shares

    GLOBENEWSWIRE

    BioMed X, Novo Nordisk Launch Oral Peptide Delivery Project

    CONTRACTPHARMA

    Novo Nordisk Unveils $499 Cash-Pay Ozempic Offering

    FIERCE PHARMA

    Novo Nordisk cuts Ozempic® price to $499/month for self-paying

    PR NEWSWIRE

    GoodRx, Novo Nordisk To Offer Ozempic And Wegovy At $499/Month

    BUSINESSWIRE

    Novo`s Wegovy Gets Accelerated Approval for Liver Disease MASH

    REUTERS

    Obesity Drug Heavyweights` Battle

    FIERCE PHARMA

    GLP-1s: The Cause of Novo Nordisk`s Swift Rise and Fall

    BIOSPACE

    Novo Nordisk A/S: Board Members, Executives Trade Shares

    GLOBENEWSWIRE

    Obesity Leaders Fortify Injectable GLP-1 Empires With Manufacture

    BIOSPACE

    Novo Nordisk A/S: Board Members and Executives Trade Shares

    GLOBENEWSWIRE

    Gilead Ends Last MASH Program, Drops 2 Cancer Assets

    FIERCE BIOTECH

    Novo Nordisk`s Wegovy, Mounjaro sales double in India in July

    ECONOMICTIMES

    Weight-Loss Drug Mounjaro Crosses Rs 100 Crore Sales in 4 Months

    ECONOMICTIMES

    Novo Nordisk Discloses Board and Executive Share Trades

    GLOBENEWSWIRE

    Novo Nordisk Drops 2 Obesity Drugs as Part of Major Clearout

    FIERCE BIOTECH

    Novo`s new CEO Takes Over at Difficult Time for Drugmaker

    FIERCE PHARMA

    Novo to Advance Prothena`s Coramitug into Phase 3 for Amyloidosis

    BUSINESSWIRE

    Novo Nordisk Broadens Legal Action to Safeguard Us Patients

    PR NEWSWIRE

    Novo Nordisk Sues Over 14 Unapproved Semaglutide Drugs in New

    INDPHARMAPOST

    Novo Nordisk`s Sales Surge 18% at Constant Exchange Rates to DKK

    GLOBENEWSWIRE

    Wegovy maker Novo Nordisk to Reduce Costs After $95 billion stock

    REUTERS

    Novo Faces Lawsuit Over Semaglutide Sales Projections

    FIERCE PHARMA

    Issues at Novo Nordisk`s Indiana site trip up Regeneron again

    FIERCE PHARMA

    Maziar Mike Doustdar Named Novo Nordisk`s President and CEO

    INDPHARMAPOST

    FDA Approves Alhemo for Hemophilia A/B Treatment in Children

    PR NEWSWIRE

    Obesity Drug Trials Underway in Big and Small Pharma Labs

    ECONOMICTIMES

    FuturHealth to Distribute Affordable FDA-Approved GLP-1s

    PR NEWSWIRE

    Novo Nordisk Names New President & CEO

    CONTRACTPHARMA

    Novo Nordisk Reduces 2025 Sales and Profit Forecast

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.